On the search for new anticancer drugs 14: The plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT)
- Cite this article as:
- Gutierrez, P.L., Cohen, B.E., Sosnovsky, G. et al. Cancer Chemother. Pharmacol. (1985) 15: 185. doi:10.1007/BF00263883
- 28 Downloads
We defined the plasma and tissue concentrations and pharmacokinetics of SL-O-TT, a spin-labeled analog of thio-TEPA, in 35–44-g male Swiss Wesbster mice that had received spin-labeled thio-TEPA at a dosage of 10 mg/kg. Concentrations of spin-labeled thio-TEPA in ethyl acetate extracts of tissue and plasma were determined by gas-liquid chromatography and electron spin resonance spectroscopy. Plasma concentrations of spinlabeled thio-TEPA declined in a biexponential fashion that was well described by the equation: Ç = 21.5e-0.276t + 2.30e-0.026t indicating a half-life alpha of 2.5 min and a half-life beta of 26.6 min. After 2h there was still spin-labeled thio-TEPA in plasma, but not in tissues. In tissues, no spin-labeled thio-TEPA was detected with gas-liquid chromatography 15 min after injection, but with electron-spin resonance label was found in lung and skeletal muscle. the main metabolite of spin-labeled thio-TEPA is spin-labeled TEPA, where oxidative desulfurization is invoked as the main metabolic mechanism. Reduction of the spin label to the hydroxylamine was also observed with time.